scholarly article | Q13442814 |
P2093 | author name string | Jie Zhang | |
Lei Du | |||
Dan Luo | |||
Xinhao Liu | |||
P2860 | cites work | The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 Study | Q22241915 |
Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death | Q34171574 | ||
Role of endothelin-1 in hypertension and vascular disease | Q34285581 | ||
The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series | Q34340908 | ||
Vasopressin versus norepinephrine infusion in patients with septic shock. | Q34756330 | ||
Pro: anesthesiologists' role in treating refractory angina: spinal cord stimulators, thoracic epidurals, therapeutic angiogenesis, and other emerging options | Q35216565 | ||
Symmetrical peripheral gangrene: association with noradrenaline administration | Q35614114 | ||
Role of endothelial dysfunction in atherosclerosis | Q35806066 | ||
Bosentan therapy for pulmonary arterial hypertension | Q35827895 | ||
Treatment of pulmonary arterial hypertension | Q35905944 | ||
Regulation of blood flow in the microcirculation | Q36086347 | ||
Survival after shock requiring high-dose vasopressor therapy | Q36664389 | ||
The brain-heart connection | Q36868231 | ||
Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice | Q37279918 | ||
The pathophysiology of endothelin in complications after solid organ transplantation: a potential novel therapeutic role for endothelin receptor antagonists | Q38049453 | ||
Arterial innervation in development and disease | Q38245885 | ||
Sympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications | Q38610953 | ||
Vasodilators in Septic Shock Resuscitation: A Clinical Perspective | Q38992493 | ||
Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial | Q42870194 | ||
The effects of vasopressin on acute kidney injury in septic shock. | Q43258485 | ||
Insertion/deletion polymorphism in alpha2-adrenergic receptor gene is a genetic risk factor for sudden cardiac death | Q43271248 | ||
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial | Q43277549 | ||
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study | Q43764381 | ||
Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline | Q44272753 | ||
Macitentan and morbidity and mortality in pulmonary arterial hypertension | Q44343572 | ||
Role of Na+/H+ exchanger in acetylcholine-mediated pulmonary artery contraction of spontaneously hypertensive rats. | Q44349654 | ||
Selepressin, a new V1A receptor agonist: hemodynamic comparison to vasopressin in dogs | Q44393317 | ||
Ischemic skin lesions as a complication of continuous vasopressin infusion in catecholamine-resistant vasodilatory shock: incidence and risk factors. | Q44456721 | ||
High-dose vasopressin is not superior to norepinephrine in septic shock* | Q44647389 | ||
The effect of vasopressin on gastric perfusion in catecholamine-dependent patients in septic shock | Q44686390 | ||
Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart | Q45201340 | ||
Effects of high thoracic epidural analgesia on myocardial blood flow in patients with ischemic heart disease | Q46455358 | ||
Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. | Q46573264 | ||
Attenuation of vasopressin-mediated coronary constriction and myocardial depression in the hypoxic heart | Q46776275 | ||
Vasopressors induce passive pulmonary hypertension by blood redistribution from systemic to pulmonary circulation | Q47323616 | ||
Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. | Q47372748 | ||
Endothelial signaling and the dynamic regulation of arterial tone: A surreptitious relationship. | Q48112224 | ||
Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. | Q52519871 | ||
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? | Q54299949 | ||
An insertion/deletion polymorphism in the α2b-adrenergic receptor gene is a novel genetic risk factor for acute coronary events | Q57303695 | ||
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 | Q64040037 | ||
Endothelins in cardiovascular biology and therapeutics | Q64443714 | ||
Role of alpha 2-adrenoceptors in normal and atherosclerotic human coronary circulation | Q67521427 | ||
Effect of endothelin-1 in man | Q68499122 | ||
Vasopressin deficiency contributes to the vasodilation of septic shock | Q73120268 | ||
Nerve sprouting and sudden cardiac death | Q73675155 | ||
The sympathetic nervous system and ischaemic heart disease | Q74747801 | ||
Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries | Q77367245 | ||
Sympathetic overactivity in ischaemic heart disease | Q79797032 | ||
Cardiac sympathetic nerve activity and ventricular fibrillation during acute myocardial infarction in a conscious sheep model | Q79975168 | ||
Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy | Q82711415 | ||
Bosentan therapy for pulmonary arterial hypertension | Q84631378 | ||
Acute coronary syndromes without obstructive coronary atherosclerosis: the tiles of a complex puzzle | Q88109424 | ||
P4510 | describes a project that uses | ImageQuant | Q112270642 |
P433 | issue | 1 | |
P304 | page(s) | 15383 | |
P577 | publication date | 2020-09-21 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Distribution and relative expression of vasoactive receptors on arteries | |
P478 | volume | 10 |
Search more.